Sr. No.. |
Particulars |
Vol & No |
Months |
Year |
1 |
Discrepancies in ABO grouping |
XIV (1) |
Jan-Feb |
1983 |
2 |
Data analysis of HBsAg testing workshop |
XIV (2) |
Mar-Apr |
1983 |
3 |
Cell surface marker studies using monoclonal antibodies |
XIV (3) |
May-June |
1983 |
4 |
Atypical blood group antibodies in blood group transfusion practice |
XIV (4) |
July-Aug |
1983 |
5 |
2 nd HLA workshop on serum screening quality control. |
XV (5) |
Sept-Oct |
1983 |
6 |
Application of cell separator machines |
XV (6) |
Nov-Dec |
1983 |
7 |
Distribution of some genetic markers with special reference to Western India. |
XV (1) |
Jan-Feb |
1984 |
8 |
HLA, Biological anthropology and India. |
XV (2) |
Mar-Apr |
1984 |
9 |
Immunohaematological aspects of the complement system. |
XV (3) |
May-June |
1984 |
10 |
Profile of immune response in iron deficiency system. |
XV (4) |
July-Aug |
1984 |
11 |
Impact of the HLA system on immunogenetic research. |
XV (5) |
Sep-Oct |
1984 |
12 |
Recent concepts in management of Rh haemolytic disease of the newborn. |
XV (6) |
Nov-Dec |
1984 |
13 |
Human blood |
XVI (1) |
Jan-Feb |
1985 |
14 |
Preparation and function of platelet components made in glass bottles. |
XVI (2) |
Mar-Apr |
1985 |
15 |
Outline of biochemical changes of blood coagulation and coagulation disorders |
XVI (3) |
May-June |
1985 |
16 |
Red cell serology in blood bank: an excercise in quality control |
XVI (4) |
July-Aug |
1985 |
17 |
Immunofluorescent techniques in immunohaematology |
XVI (5) |
Sep-Oct |
1985 |
18 |
Preservation of red cells in pilot tubes in blood banks. |
XVI (6) |
Nov-Dec |
1985 |
19 |
Platelet transfusion and thrombocytopenic haemorrhagic disorders |
XVII (1) |
Jan-Feb |
1986 |
20 |
Hodgkin’s disease: historical perspective current status and future directions |
XVII (2) |
Mar-Apr |
1986 |
21 |
Prenatal diagnosis of hemoglobinopathies |
XVII (3) |
May-Jun |
1986 |
22 |
Acquired immune deficiency syndrome,(AIDS) its impact on blood transfusion services |
XVII (4) |
Jul – Aug |
1986 |
23 |
Immunoblotting in Immunohaematology |
XVII (5) |
Sept-Oct |
1986 |
24 |
ELISA Today |
XVII (6) |
Nov-Dec |
1986 |
25 |
Genetic parameters: Biologic and epidemiologic significance |
XVIII (1) |
Jan-Feb |
1987 |
26 |
Application of recombinant DNA technology for gene mapping of immunoglobulins |
XVIII (2) |
Mar-Apr |
1987 |
27 |
C1q the first complement component -A review |
XVIII (3) |
May-June |
1987 |
28 |
Chemistry of FVIII molecule |
XVIII (4) |
July-Aug |
1987 |
29 |
Genetics and epidemiology of Sickle cell anemia in India |
XIX (1) |
Jan-Feb |
1988 |
30 |
Intravenous immunoglobulin (IVIG) therapy – an alternate approach in the treatment of Idiopathic Thrombocytopenic Purpura (ITP) |
XIX (2) |
Mar-April |
1988 |
31 |
The red cell membrane and it’s vesiculation |
XIX (3) |
May-Jun |
1988 |
32 |
Structure and genetic aspects of the HLA systems |
XIX (4) |
July-Aug |
1988 |
33 |
Institute of Immunohaematology – referral services |
XIX (5) |
Sep-Oct |
1988 |
34 |
Neonatal thrombocytopenia |
XIX (6) |
Nov-Dec |
1988 |
35 |
Recent developments in transfusion medicine (The first Dr. H. M. Bhatia Memorial Oration) |
XX (1) |
Jan-Feb |
1989 |
36 |
Community control of β-thalassemia |
XX (2) |
Mar-Apr |
1989 |
37 |
Antibody dependent cell mediated phagocytosis and cytolysis |
XX (3) |
May-June |
1989 |
38 |
The H antigen of the ABO blood group system |
XX (4) |
Jul-Aug |
1989 |
39 |
AIDS and HIV infection: An Epidemiological overview |
XX (5) |
Sep-Oct |
1989 |
40 |
Health education in sickle cell disease |
XX (6) |
Nov-Dec |
1989 |
41 |
1)Studies on some aspects of the HLA system
2) HLA studies at the Cancer Research Institute (The Second Dr. H.M.Bhatia Memorial Oration) |
XXI (1) |
Jan-Mar |
1990 |
42 |
Preliminary report of blood component therapy (CT) experience at K.E.M. blood bank |
XXI (2) |
Apr- June |
1990 |
43 |
Monoclonal antibodies in Hematology : Some less known facts |
XXI (3) |
July-Sept |
1990 |
44 |
World congress on AIDS – Some highlights and update |
XXI (4) |
Oct-Dec |
1990 |
45 |
A report on blood banking in India |
XXII (1) |
Jan-Mar |
1991 |
46 |
Erythrocytes G6PD deficiency and its variants in West Bengal (The IIIrd Dr. H. M.Bhatia memorial oration) |
XXII (2) |
Apr-Jun |
1991 |
47 |
Genetic red cell defects and malaria |
XXII(3-4) |
July-Dec |
1991 |
48 |
Highlights of the XVIth Annual conference of the Bombay Haematology group (BHG) |
XXIII (1) |
Jan-Feb |
1992 |
49 |
Molecular approaches to the detection of agents in persistent viral infections (The IV Dr.H.M.Bhatia Memorial Oration) |
XXIII (2) |
Mar-Apr |
1992 |
50 |
Quality assurance in blood bank |
XXIII (3) |
May-Jun |
1992 |
51 |
Preventive Hematology |
XXIII (4) |
July-Aug |
1992 |
52 |
Autologus Transfusion |
XXIII (5) |
Sep-Oct |
1992 |
53 |
Hematopoietic growth factors : Colony stimulating factors |
XXIII (6) |
Nov-Dec |
1992 |
54 |
Glucose-6- Phosphate Dehydrogenase deficiency and its variants in India ( The V Dr.H.M.Bhatia Memorial Oration) |
XXIV (1-3)
|
Jan-Jun |
1993 |
55 |
The Anti-Idiotype network in systemic lupus erythematosus – A Review |
XXIV (4)
|
Jul-Sept |
1993 |
56 |
Recent advances in the management of Rh Hemolytic disease of the newborn (HDN) |
XXIV (5)
|
Oct-Dec |
1993 |
57 |
Blood transfusion (Red Cell) practices and policy for the Neonate |
XXV (1)
|
Jan-Apr |
1994 |
58 |
Apoptosis |
XXV (2) |
May-Aug |
1994 |
59 |
The Haemopoietic progenitor cell |
XXV (3) |
Sept-Dec |
1994 |
60 |
Current concepts in the immunology of allograft rejection |
XXVI (1) |
Jan-Apr |
1995 |
61 |
Megaloblastosis, a morphologic expression of molecular derangementsin DNA and histone biosynthesis (The VI Dr.H.M.Bhatia Memorial Oration)
|
XXVI (2&3) |
May-Dec |
1995 |
62 |
Pretransplant blood transfusions in renal transplantation—Are They Beneficial? |
XXVII (1) |
Jan-Jun |
1996 |
63 |
Cell Adhesion molecules in Haemopoiesis |
XXVII (2) |
Jul-Dec |
1996 |
64 |
Bone marrow transplantation for thalassemia (The IX Dr.H.M.Bhatia Memorial Oration) |
XXVIII (1) |
Jan-June |
1997 |
65 |
Chromosomal changes in acute leukemia |
XXVIII (2) |
July-Dec |
1997 |
66 |
An overview of the blood programme in India and the need for revamping (The X Dr.H.M.Bhatia Memorial Oration) |
XXIX (1) |
Jan-April |
1998 |
67 |
Donor selection for allogeneic bone marrow transplantation |
XXIX (2) |
May-Aug |
1998 |
68 |
Prevention of Rh alloimmunization and management of Rh (D) haemolytic disease of the newborn by Intrauterine transfusion |
XXIX (3) |
Sept-Dec |
1998 |
69 |
Progress in Technology for detection of mutations in hematological disorders |
XXX (1) |
Jan-April |
1999 |
70 |
Bone Marrow density study in Patients with Thalassemia Major- A Preliminary Evaluation (The XI Dr.H.M.Bhatia Memorial Oration) |
XXX (2) |
May-Aug |
1999 |
71 |
Hemophilia- From diagnosis to prevention |
XXX (3) |
Sept-Dec |
1999 |
72 |
Health Problems of Tribal Population Groups from the State of Maharashtra (The XII Dr.H.M.Bhatia Memorial Oration) |
XXXI (1) |
Jan-Apr |
2000 |
73 |
Resolving problems in pre transfusion investigations in blood group serology |
XXXI (3) |
Sept-Dec |
2000 |
74 |
Allogenic bone marrow transplantation : looking back and planning ahead (The XIII Dr.H.M.Bhatia Memorial Oration) |
XXXII (1) |
Jan-April |
2001 |
75 |
ANCA-Anti-Neutrophil Cytoplasmic Antibodies and their role in vasculitis associated kidney disorders |
XXXII (3) |
May-Aug |
2001 |
76 |
Monoclonal antibodies – An overview |
XXXII (3) |
Sept-Dec |
2001 |
77 |
My Experiences from Blood Components to Fractionation at KEM Hospital, Mumbai and SGPGIMS, Lucknow.(The XIV Dr.H.M.Bhatia Memorial Oration) |
XXXIII (1) |
Jan-Apr |
2002 |
78 |
Air Travel & Deep Vein Thrombosis |
XXXIII (2) |
May-Aug |
2002 |
79 |
Diagnostic assays for detection of HIV infection |
XXXIII (3) |
Sept-Dec |
2002 |
80 |
Indian and genetic diversity in the genomic era: implications in health & disease (The XV Dr.H.M.Bhatia Memorial Oration) |
XXXIII (2) |
Jan-Apr |
2003 |
81 |
Molecular genetics of sickle cell disease : an overview |
XXXIV (2) |
May-Aug |
2003 |
82 |
Umbilical cord blood: biology of hematopoietic stem cells and their applications |
XXXIV (3) |
Sept-Dec |
2003 |
83 |
Current status of understanding biology and management of chronic myeloid leukemia (The XVI Dr.H.M.Bhatia Memorial Oration)
|
XXXV (1) |
Jan-Apr |
2004 |
84 |
Concepts of confocal microscopy |
XXXV (2) |
May-Aug |
2004 |
85 |
Fetal hemoglobin levels in adults |
XXXV (3) |
Sept-Dec |
2004 |
86 |
Strategies for ensuring safe and blood products (The XVII Dr.H M Bhatia memorial oration) |
XXXVI (1) |
Jan-April |
2005 |
87 |
Human platelet specific antigens and neonatal alloimmune thrombocytopenic purpura (NAITP) |
XXXVI (2) |
May-Aug |
2005 |
88 |
Immunodiagnosis of some rheumatic and autoimmune diseases : An overview |
XXXVI (2) |
Sept-Dec |
2005 |
89 |
Hereditary hemolytic anemia due to Pyruvate kinase deficiency (The XVIII Dr. H M Bhatia Memorial Oration) |
XXXVII (1) |
Jan-April |
2006 |
90 |
Non invasive prenatal diagnosis – A Review |
XXXVII (2) |
May-Aug |
2006 |
91 |
Arrray comparative genomic hybridization - An efficient tool for genome analysis
|
XXXVII (3) |
Sept-Dec |
2006 |
92 |
Coagulation disorders seen through the window of molecular biology |
XXXVIII (1) |
Jan-Apr |
2007 |
93 |
The complexities of the ABO blood group system (past & present) |
XXXVIII (2) |
May-Aug |
2007 |
94 |
Human red cell pyruvate kinase (PK) deficiency |
XXXVIII (3)
|
Sep-Dec |
2007 |
95 |
a) Dr. Kanjaksha Ghosh, Institute of Immunohematology (IIH) becomes National Institute of Immunohematology (NIIH)
b) Maya Gupta, Manisha Madkaikar, Recent Trends in diagnosis of Paroxysmal
nocturnal haemoglobinuria
|
XXXIX (1) |
Jan-Apr |
2008 |
96 |
Dr. V. Babu Rao, Genetic and Molecular pathology of Fanconi Anemia
|
XXXIX (2) |
May-Aug |
2008 |
97 |
Immunogenetics of ANCA associated vasculitis (AAV) review |
Vol. XXXIX(3) |
Sept-Dec |
2008 |
98 |
Dr. H.M. Bhatia Oration- The Hemoglobinopathies-Thalassemia and Sickle Cell Disease: Paths of Progress- David G. Nathan (President Emeritus, Dana-Farber Cancer Institute, Boston USA. |
Vol.XXXX(1) |
Jan-Apr |
2009 |
99 |
The Use of Hydroxyurea in Sickle Cell Disease |
Vol. XXXX(2) |
May-Aug |
2009 |
100 |
Haemophagocytic Lymphohistiocytosis: Clinical features, pathogenesis and treatment |
Vol.XXXX(3) |
Sep-Dec |
2009 |
101 |
Dr. H.M. Bhatia Oration- Some lessons from the interface of Genetics and Hematology |
Vol. XXXXI(1) |
Jan-Apr |
2010 |
102 |
Rhesus blood group system- structure and function
|
Vol.XXXXI(2) |
May-Aug |
2010 |